Verastem, Inc.
Records under this name other than the patents Verastem, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 6 of 6 · Back to Verastem, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,138,437 | Pyrimidine substituted purine compounds as kinase (S) inhibitors Lapsed on the fee record Ended Sep 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | From the USPTO record |
| US 8,754,080 | Pyrimidine substituted purine compounds as kinase (S) inhibitors Lapsed on the fee record Ended Jun 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2022 | From the USPTO record |
| US 8,609,838 | Pyrimidine substituted purine derivatives Lapsed on the fee record Ended Dec 17, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 17, 2021 | From the USPTO record |
| US 9,505,719 | Synthesis and use of kinase inhibitors Lapsed on the fee record Ended Nov 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 29, 2020 | From the USPTO record |
| US 8,247,410 | Pyrimidine substituted purine derivatives Lapsed on the fee record Ended Aug 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 21, 2020 | From the USPTO record |
| US 9,375,402 | Oral formulations of kinase inhibitors Lapsed on the fee record Ended Jun 28, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2020 | From the USPTO record |